SCHEMBL14763343

SCHEMBL14763343

COc1c(Cl)cccc1-c1ccc(Cl)c(OC)c1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.46
▸ NPC1 O15118 2/20 0.46
▸ RAB9A P51151 2/20 0.46
▸ PKM P14618 1/20 0.46
▸ MAPT P10636 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ MEP1B Q16820 1/20 0.38
▸ ABCG2 Q9UNQ0 1/20 0.37
▸ TAS1R3 Q7RTX0 1/20 0.37
▸ TAS1R1 Q7RTX1 1/20 0.37
▸ TAS1R2 Q8TE23 1/20 0.37
▸ PDCD1LG2 Q9BQ51 2/20 0.36
▸ CD274 Q9NZQ7 2/20 0.36
▸ CCNT1 O60563 1/20 0.36
▸ CDK9 P50750 1/20 0.36
▸ MAPK10 P53779 1/20 0.36
▸ MAPK14 Q16539 1/20 0.36
▸ CTSA P10619 1/20 0.34
▸ MME P08473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18244619 0.88 ALDH1A1 (0.45) KDM4ENPC1RAB9APKMALDH1A1
SCHEMBL29398790 0.85 KDM4E (0.44) KDM4ENPC1RAB9APKMMAPT
SCHEMBL21192814 0.85 KDM4E (0.44) KDM4ENPC1RAB9APKMMAPT
SCHEMBL14769021 0.85 KDM4E (0.39) KDM4ENPC1RAB9APKMMAPT
SCHEMBL29536435 0.84 KDM4E (0.43) KDM4ENPC1RAB9APKMMAPT
SCHEMBL21891045 0.84 KDM4E (0.43) KDM4ENPC1RAB9APKMMAPT
SCHEMBL22315720 0.80 L3MBTL1 (0.46) KDM4ENPC1RAB9APKMMAPT
SCHEMBL31070121 0.77 CHRM5 (0.40) KDM4ENPC1RAB9APKMMAPT
SCHEMBL31355179 0.76 EGLN2 (0.42) KDM4ENPC1RAB9AMAPTCTSA
SCHEMBL21906407 0.76 FABP4 (0.43) KDM4ENPC1RAB9APKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2755980-B1 METHODS AND SYSTEMS FOR FORMING BORONIC ACIDS AND INTERMEDIATES THEREOF DOW AGROSCIENCES LLC (US) 2019-10-30 — — EP disclosed
EP-2755980-B1 METHODS AND SYSTEMS FOR FORMING BORONIC ACIDS AND INTERMEDIATES THEREOF DOW AGROSCIENCES LLC (US) 2019-10-30 — — EP disclosed
US-9145428-B2 Methods and systems for forming boronic acids and intermediates thereof DOW AGROSCIENCES LLC (US) 2015-09-29 — — US disclosed
US-9145428-B2 Methods and systems for forming boronic acids and intermediates thereof DOW AGROSCIENCES LLC (US) 2015-09-29 — — US disclosed
WO-2013040479-A1 METHODS AND SYSTEMS FOR FORMING BORONIC ACIDS AND INTERMEDIATES THEREOF DOW AGROSCIENCES LLC (US) 2013-03-21 — — WO disclosed
US-20130066115-A1 METHODS AND SYSTEMS FOR FORMING BORONIC ACIDS AND INTERMEDIATES THEREOF DOW AGROSCIENCES LLC (US) 2013-03-14 — — US disclosed
US-20130066115-A1 METHODS AND SYSTEMS FOR FORMING BORONIC ACIDS AND INTERMEDIATES THEREOF DOW AGROSCIENCES LLC (US) 2013-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130066115-A1 METHODS AND SYSTEMS FOR FORMING BORONIC ACIDS AND INTERMEDIATES THEREOF BLVRB, AKR7A2, HAO2 KDM4E 2793/4885NPC1 1149/4885RAB9A 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback